CXCL12 and carcinoma: This may be a new perspective to explore the immune mechanism and immunotherapy for cancer.Notably, studies have reported Notch signaling has been implied in mediating chemotaxis system CXCL12/CXCR4 promoted carcinoma metastasis and multiple myelom [45].